Finishing treatment for tuberculosis (TB) is a major milestone. For most patients, it means the infection has been cleared and the risk of spreading the disease has ended.
But new research suggests that for some people, recovery does not stop there. Changes left behind in the lungs after TB may increase the risk of developing further infections months or even years later.
A study from scientists at A*STAR Infectious Diseases Labs (IDL) in Singapore helps explain why people with a history of TB are more likely to develop other serious lung infections, particularly those caused by non‑tuberculous mycobacteria.
TB and lasting lung damage
TB is caused by the bacterium Mycobacterium tuberculosis and primarily affects the lungs. During infection, the immune system forms structures called granulomas (like a immune “prison” for the bad germ). These are tight clusters of immune cells that wall off the bacteria to limit their spread.
Granulomas are a normal part of the body’s defence against TB. However, they can leave behind scarring and areas of damaged tissue, even after antibiotic treatment has successfully killed the TB bacteria.
In Both Malaysia and Singapore, TB remains a public health concern. At the same time, infections caused by non‑tuberculous mycobacteria, or NTM, have been increasing steadily and now exceed TB diagnoses in many countries.
One NTM species of particular concern is Mycobacterium abscessus, which can cause chronic lung disease and is often difficult to treat.
A long‑standing clinical puzzle
Doctors have long noticed that many patients with NTM lung infections have had TB in the past. Studies in Singapore suggest that about one in three people diagnosed with NTM disease also have a previous history of TB.
The findings do not change current advice about TB treatment. Completing the full course of antibiotics remains essential and highly effective at curing TB.
Until now, it has not been clear why this link exists. The new study, published in Nature Communications, provides a biological explanation that connects past TB infection with later vulnerability to other bacteria.
What the new research shows
The researchers used adult zebrafish, a well‑established animal model for studying mycobacterial infections, to investigate what happens when a second lung infection occurs after TB.
They found that Mycobacterium abscessus rapidly moved into pre‑existing TB granulomas formed by Mycobacterium marinum, a close relative of the TB bacterium used for research. Inside these granulomas, the secondary bacteria survived and multiplied.
In contrast, bacteria that remained outside the granulomas were quickly controlled by the immune system and cleared.
In simple terms, structures formed during the original TB infection appeared to provide a safe hiding place for new bacteria.
How granulomas can shelter bacteria
Further experiments showed why granulomas can be so protective. The centres of these structures often contain dead and damaged tissue. Mycobacterium abscessus was able to use this material as a food source, allowing it to adapt and grow in an otherwise hostile environment.
Being inside a granuloma also reduced the bacteria’s exposure to immune cells and antibiotics. Once established, the secondary infection grew faster than the original TB infection had.
These findings suggest that even when TB bacteria are eliminated, the granulomas they leave behind may continue to influence lung health.
How strong is the evidence?
The study was carried out in an animal model, not in humans, which means the findings cannot be directly translated into patient care.
However, zebrafish models are widely used to study TB‑like infections because their immune responses share important features with those of humans.
The results also align closely with clinical observations in people, including the high rate of NTM disease among those with a history of TB.
Together, this strengthens the case that persistent lung changes after TB play a role in later infections.
What this means for patients
The findings do not change current advice about TB treatment. Completing the full course of antibiotics remains essential and highly effective at curing TB.
However, the research highlights the importance of follow‑up care after treatment ends. Some patients may be left with lasting lung damage that increases their vulnerability to other infections. Monitoring symptoms such as chronic cough, breathlessness or repeated chest infections may help identify problems earlier.
As the study’s author noted, completing TB treatment does not always mean the lungs return to normal.
Implications for treatment and prevention
Current TB treatment focuses on killing the bacteria, rather than on repairing lung damage or resolving granulomas.
The new findings suggest that strategies aimed at reducing or healing these structures earlier could potentially lower the risk of secondary infections.
For now, there are no specific treatments designed to remove granulomas once TB has been cured. Any changes to clinical practice would require further research, including studies in people.
What remains unknown
Many questions are still unanswered. It is not clear how often persistent granulomas lead to later infections, or which patients are most at risk. Researchers also need to determine whether similar processes occur in human lungs over longer periods.
Future studies may explore whether imaging, lung function tests or targeted therapies could help identify and protect patients who remain vulnerable after TB.
A broader view of recovery after TB
The study adds to growing evidence that recovery from TB can extend well beyond the end of antibiotic treatment. While most people recover well, some may carry lasting changes in their lungs that shape future health.
Understanding these long‑term effects is an important step towards improving care for TB survivors, not just in Malaysia or Singapore but worldwide, as attention shifts from curing infection to prevention, and supporting full and lasting recovery.
The post Why Lung Infection Risks Can Persist Even After Tuberculosis Treatment first appeared on PP Health Malaysia.
